How did Transmedics Group Inc perform in its last earnings report?

On 2026-11-05, Transmedics Group Inc reported EPS of 0.49 and +69.70% EPS surprise. Revenue was 203.00M, compared with the consensus estimate of 177.58M.

What does an earnings surprise mean?

An earnings surprise is the difference between a company's reported EPS or revenue and the analysts' consensus estimate. A positive surprise means results exceeded expectations, while a negative surprise means results fell short.

How can earnings reports affect TMDX stock?

Earnings reports can increase volatility in TMDX stock, especially when reported EPS, revenue or company guidance differs from market expectations. An earnings beat does not always lead to a price increase, as investors also consider the outlook, valuation and broader market conditions.

Transmedics Group Inc Earnings Dates & Reports

This page offers detailed Transmedics Group Inc earnings data including the latest Transmedics Group Inc earnings report, the upcoming Transmedics Group Inc earnings date, historical data and Transmedics Group Inc earnings call news.

TMDX Latest Quarter’s Earnings

Announce Date11/5/2026

EPS Actual (USD)0.49

Revenue Actual (USD)203.00M

TMDX Upcoming Quarter's Earnings

Announce Date--

EPS Forecast (USD)--

Revenue Forecast (USD)--

TMDX FY2025 Earnings

EPS (YoY)5.60424.53%

Revenue (YoY)605.49M37.13%

Transmedics Group Inc (TMDX) Earnings History

Release Date	Period End	EPS/Forecast	Revenue/Forecast	EPS Surprise %	Revenue Surprise %
11/5/2026	09/2026	0.49/0.29	203.00M/177.58M	68.60%	14.32%
8/4/2026	06/2026	0.42/0.47	189.95M/183.64M	-10.30%	3.44%
5/5/2026	03/2026	0.21/0.61	173.93M/172.64M	-65.28%	0.75%
2/24/2026	12/2025	3.08/0.39	160.76M/155.72M	687.73%	3.24%
10/29/2025	09/2025	0.71/0.35	143.82M/145.26M	103.16%	-0.99%
7/30/2025	06/2025	1.03/0.45	157.37M/147.86M	128.29%	6.43%
5/8/2025	03/2025	0.76/0.26	143.54M/123.66M	196.72%	16.07%
2/27/2025	12/2024	0.20/0.16	121.62M/110.29M	27.57%	10.28%

Transmedics Group Inc Latest Earnings Call Transcripts

TransMedics (TMDX) Q3 2026 Earnings Call: Record Revenue and Higher Guidance

TransMedics Q3 2026 earnings call: revenue rose 41% to $203 million, margins improved excluding PAD, and 2026 guidance increased to $764 million–$774 million.